Recent

% | $
Quotes you view appear here for quick access.

Mylan N.V. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Little Bobby Coury

    by billthedill 10 hours ago

    This disaster playing out reminds me of the letter the school marm sent to the governor regarding his choce of sheriff sent to their town. She wrote " your sending this man just goes to show, beyond a doubt , that you are the biggest ***hole in this entire state." the movie : {'BLAZING SADDLES } . Guess who the governor is in this financial fiasco ?

  • Reply to

    Myl

    by catchup440 Aug 2, 2015 9:19 PM

    You can always delete that post if catchup is right.

  • Reply to

    Little Bobby Coury

    by billthedill 10 hours ago

    the dopes are those still holding shares of Coury's folly.

  • The DOPE of all dopes!!!!! Nice job loser!

  • Ultimate stock alerts has consistently been delivering me with 100s in profits weekly. It is nothing major but it is a nice boost for only a few hours of work. No complaints about ultimatestockalerts here.

  • Reply to

    Myl

    by catchup440 Aug 2, 2015 9:19 PM

    He is DUMB!!!!! Cost shareholders BILLIONS!!!!

  • Reply to

    Myl

    by catchup440 Aug 2, 2015 9:19 PM

    As a shareholder, I hope you are right. If earnings are not exceptional/blow-out, Coury is going to look really dumb.

    Sentiment: Hold

  • If MYL disappoints on earnings, will that be enough for shareholders to hold Coury accountable? As a long term shareholder, I supported the company vision for a long time. But Coury has become erratic, anti-shareholder, and destructive to long-term shareholder value. His strange and hostile behavior warrants a change. The problem with some people and power is that they start to believe their own press. Coury has gotten way to full of himself. TEVA totally outplayed Mylan and proved that they are top dog in the generic space. Coury overplayed his hand to the detriment of all shareholders AND stakeholders. Mylan's negotiating power is diminished with insurers and other takeover candidates... whether Mylan is the acquirer or the acquired. We cant afford to take over Perrigo now (too much dilution) and are unlikely to get an offer like TEVA would have paid... mid to high 80s... which would now represent an almost 60% premium to current trading levels. Anyone looking to buy would undoubtedly offer low 70s... which would represent a 30% premium to where we currently trade. Coury had no plan B. For his sake (and ours) MYL better crush earnings, or we are headed back to the 40s.

    Sentiment: Hold

  • I said then that if MYL blows off the Teva deal that the stock would immediately fall to the high 50s. Ok, I was off...it fell to the MID 50s. It was pretty obvious that Coury was never going to allow the shareholders to profit...that is not in his world/corporate view. The second part of that post is what worries me now. Next move is to add on some massive debt in a big useless "deal" that will burden the company with massive debt leading into the next market downturn. At least he did not order a big buyback of stock at $75! The casual observer would have to conclude that he is acting in a totally self serving manner with no thought for the shareholders best interests and that is proven by his idiotic responses to the TEVA offer and the payment of management's capital gains after the inversion.

  • Reply to

    Accountability

    by gthcgd 14 hours ago

    Thieves!

  • Reply to

    Myl

    by catchup440 Aug 2, 2015 9:19 PM

    You get downvoted because you're an idiot.

  • How in the world is a CEO and Board not accountable for the massive screwups and loss of shareholder value and creation of a a disastrous corporate governance structure ?
    it is fine for board members to do deals with themselves and Myl - that is ok but allowing the owners of the company to decide its fate is against the interests of stakeholders

    Coury and board should rot in the boardroom of corporate hell

  • I`ve been following this since it was 9.00 With all this going on I believe Coury has a silver bullet and earnings will be out standing

  • Reply to

    Coury Mylan Management and BOD should be voted out

    by ilmplm Aug 2, 2015 12:54 AM

    MYL management seems too hostile to being taken over, they want to be the suitor which depresses the stock. No buyout premium. Problem is MYL doesn't have the capital to continue buying out other companies, they do a lot of share offer purchases which dilutes current MYL shareholders. The best for MYL shareholders would be a buyout versus waiting for the stock to try and appreciate which is slow and not always a guarantee.

  • Reply to

    TEVA did not want Mylan to buy Perrigo.

    by stocker54321 Jul 29, 2015 9:54 PM

    Teva has gone after MYL and PRGO both. If MYL gets PRGO then the company is too big for them to purchase versus if each are standalone. Teva still has shares in MYL and can always go after them again. They probably saw AGN buy more worthwhile and don't think MYL will be going anywhere anytime soon in which they can always revisit afterwards and same with PRGO.

  • Reply to

    Mylan boobs

    by sveyn_vassic Aug 1, 2015 3:13 PM

    Wrong, Coury was after PRGO for a while since 2014 and just kept getting turned down, before Teva was involved . It was made public to bring it to PRGO shareholders. PFE also tried buying Teva previously as well as Teva tried buying PRGO. It is still a possibility that PFE goes for MYL, I do know how much PFE would want MYL after if combined with PRGO. PFE already split from some businesses that PRGO has such as animal healthcare and other PRGO business do not make so much sense for PFE. Makes more sense to get MYL before they get PRGO as it would be a good fit for their PFE generics side. If MYL gets PRGO I don't see PFE going for them afterwards. If MYL get PRGO then MYL will most likely be a standalone business.

    Sentiment: Hold

  • Reply to

    TEVA did not want Mylan to buy Perrigo.

    by stocker54321 Jul 29, 2015 9:54 PM

    Small cost of doing business.

  • Reply to

    Mylan boobs

    by sveyn_vassic Aug 1, 2015 3:13 PM

    Moody places Mylan debt to negative with the potential of chasing Perrigo and ultimately overpaying.

    And analysts are against a Mylan-Perrigo combination. Here are some comments from a story in the Pittsburg Business News Journal.

    Leerink & Co. LLC analysts don’t believe a Mylan/Perrigo deal is likely unless Mylan ups the ante to $39 billion, or $230 per share. Perrigo rejected Mylan’s prior offer of $205 per share.

    “We do not believe Mylan has the financial firepower to make an acceptable bid for Perrigo or construct a deal that is value-creating for Mylan shareholders,” Leerink analysts Jason Gerberry and Derek Archila wrote in a report released Tuesday. “We expect Mylan shareholders to vote against a Perrigo deal."

    Cowen & Co. doesn’t view the Perrigo (NYSE: PRGO) transaction as being wealth-creating for Mylan, and since it is not expected to become accretive until year four, believe that’s something “shareholders will have a tough time stomaching.” If Mylan raises its bid above the $205 per share offer, “the deal gets incrementally more negative,” according to the report by Cowen analysts Ken Cacciatore, Tyler Van Burner and Sal Rais. “Mylan management can now face what we believe to be the inevitable painful music from their shareholders.”
    Ronny Gal, senior analyst at Sanford Bernstein & Co., said in an email to the Pittsburgh Business Times he was still mulling whether Mylan will wind up buying Perrigo.

    Sentiment: Hold

  • Reply to

    Mylan boobs

    by sveyn_vassic Aug 1, 2015 3:13 PM

    You are wrong. Teva did not use Mylan. Allergan used Mylan and Coury's vitriolic attitude to win Teva back to the bargaining table.

    Teva will pay Allergan the same amount of money that it offered to purchase Mylan. Allergan's generic business generates approximately 30% less revenue compared to all of Mylan. So Teva apparently overpaid.

    Yes, in 2014, Teva initially approached Allergan, then called Activis. Acticis declined. Then Teva decided to focus on its second choice. Coury is well known for his ego and his management methods that, for one thing, has relied on demonizing Teva as a competitor. Coury made the Perrigo offer shortly after being approached by Teva. It's likely His four-letter-laced response caused Teva to
    go public with its preliminary offer on April 21.

    Allergan's Saunders craftily used Coury's public vitriol and Mylan legal, and stichting defense to draw Teva back to its initial interests in Allergan's generic business.

    Sentiment: Hold

Must Watch
MYL
55.20-0.79(-1.41%)Aug 3 4:00 PMEDT